Cleared Traditional

PROSOLV CARDIVASCULAR VIEWER (K023112) - FDA 510(k) Clearance

Also marketed or referenced as:
ANALYZER SERVER VERSION 2.5.9

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K023112 · Problem Solving Concepts, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2002
Decision
89d
Days
Class 2
Risk

K023112 is an FDA 510(k) clearance for the PROSOLV CARDIVASCULAR VIEWER. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Problem Solving Concepts, Inc. (Indianapolis, US). The FDA issued a Cleared decision on December 17, 2002 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Problem Solving Concepts, Inc. devices

Submission Details

510(k) Number K023112 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 19, 2002
Decision Date December 17, 2002
Days to Decision 89 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 125d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 175
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K023112.
INFINITY MEGACARE
K031970 · Siemens Medical Solutions USA, Inc. · Sep 2003
PYRAMIS ECG MANAGEMENT SYSTEM MODEL NUMBERS, 92600 AND 92601
K032038 · Quinton, Inc. · Sep 2003
LABSYSTEM III EP LABORATORY W/WINDOWS PLATFORM & WINDOWS EP SOFTWARE VERSION 1.0
K031000 · C.R. Bard, Inc. · Jun 2003
QUINTON Q-CATH, MODEL 000460
K021906 · Quinton, Inc. · Sep 2002
ASTRONOMER+WITH SLD
K003362 · Boston Scientific Corp · Mar 2001
STRESSWRITER EXERCISE TESTING SYSTEM
K961009 · Hewlett-Packard Co. · Jun 1996